How COVID-19 has fundamentally changed clinical research in global health
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
How COVID-19 has fundamentally changed clinical research in global health
Authors
Keywords
-
Journal
Lancet Global Health
Volume 9, Issue 5, Pages e711-e720
Publisher
Elsevier BV
Online
2021-04-16
DOI
10.1016/s2214-109x(20)30542-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role and challenges of cluster randomised trials for global health
- (2021) Louis Dron et al. Lancet Global Health
- Randomised trials at the level of the individual
- (2021) Jay J H Park et al. Lancet Global Health
- Urgently seeking efficiency and sustainability of clinical trials in global health
- (2021) Jay J H Park et al. Lancet Global Health
- An interactive web-based dashboard to track COVID-19 in real time
- (2020) Ensheng Dong et al. LANCET INFECTIOUS DISEASES
- Effects of progressive muscle relaxation on anxiety and sleep quality in patients with COVID-19
- (2020) Kai Liu et al. Complementary Therapies in Clinical Practice
- Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide
- (2020) Matthew Ventresca et al. BMC Medical Research Methodology
- Dosing will be a key success factor in repurposing antivirals for COVID‐19
- (2020) Patrick F. Smith et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The Late Arrival of Coronavirus Disease 2019 (COVID-19) in Africa: Mitigating Pan-continental Spread
- (2020) Jean Nachega et al. CLINICAL INFECTIOUS DISEASES
- Time to step up: A call to action for the clinical and quantitative pharmacology community to accelerate therapeutics for COVID‐19
- (2020) Dan Hartman et al. CTS-Clinical and Translational Science
- Optimizing the Trade-off Between Learning and Doing in a Pandemic
- (2020) Derek C. Angus JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- An Overview of Platform Trials with a Checklist for Clinical Readers
- (2020) Jay J.H. Park et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Efficacy of internet-based integrated intervention on depression and anxiety symptoms in patients with COVID-19
- (2020) Ning Wei et al. Journal of Zhejiang University-SCIENCE B
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- How swamped preprint servers are blocking bad coronavirus research
- (2020) Diana Kwon NATURE
- Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks
- (2020) Natalie E. Dean et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
- (2020) Jason D. Goldman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial of Instructor-Led Training Versus Video Lesson in Training Health Care Providers in Proper Donning and Doffing of Personal Protective Equipment
- (2020) Liva Christensen et al. Disaster Medicine and Public Health Preparedness
- Limiting the spread of COVID-19 in Africa: one size mitigation strategies do not fit all countries
- (2020) Shaheen Mehtar et al. Lancet Global Health
- COVID-19 Clinical Trials: A Teachable Moment for Improving Our Research Infrastructure and Relevance
- (2020) Stephen E. Kimmel et al. ANNALS OF INTERNAL MEDICINE
- Promoting Better Clinical Trials and Drug Information as Public Health Interventions for the COVID-19 Emergency in Italy
- (2020) Antonio Addis et al. ANNALS OF INTERNAL MEDICINE
- AVIFAVIR for Treatment of Patients with Moderate COVID-19: Interim Results of a Phase II/III Multicenter Randomized Clinical Trial
- (2020) Andrey A Ivashchenko et al. CLINICAL INFECTIOUS DISEASES
- Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19 (Metcovid): A Randomised, Double-Blind, Phase IIb, Placebo-Controlled Trial
- (2020) Christiane Maria Prado Jeronimo et al. CLINICAL INFECTIOUS DISEASES
- Febuxostat therapy in outpatients with suspected COVID‐19: A clinical trial
- (2020) Lotfollah Davoodi et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- SARS-CoV-2 Clearance in COVID-19 Patients with Novaferon Treatment: A Randomized, Open-label, Parallel Group Trial
- (2020) Fang Zheng et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Editorial Evaluation and Peer Review During a Pandemic
- (2020) Howard Bauchner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
- (2020) The Lancet Editors LANCET
- Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
- (2020) Mandeep R Mehra et al. LANCET
- A minimal common outcome measure set for COVID-19 clinical research
- (2020) John C Marshall et al. LANCET INFECTIOUS DISEASES
- Expression of Concern: Mehra MR et al. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.
- (2020) Eric J. Rubin NEW ENGLAND JOURNAL OF MEDICINE
- Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.
- (2020) Mandeep R. Mehra et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
- (2020) Alexandre B. Cavalcanti et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
- (2020) David R. Boulware et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Open‐Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID‐19, a Pilot Study
- (2020) Zhigang Ren et al. Advanced Science
- Antiviral Activity and Safety of Darunavir/Cobicistat for the Treatment of COVID-19
- (2020) Jun Chen et al. Open Forum Infectious Diseases
- Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
- (2020) Mayla Gabriela Silva Borba et al. JAMA Network Open
- Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study
- (2020) Sherief Abd-Elsalam et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial
- (2020) Naser Gharebaghi et al. BMC INFECTIOUS DISEASES
- Treatment of COVID-19 Patients with Prolonged Post-Symptomatic Viral Shedding with Leflunomide -- a Single-Center, Randomized, Controlled Clinical Trial
- (2020) Mengmei Wang et al. CLINICAL INFECTIOUS DISEASES
- Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial
- (2020) Maryam Edalatifard et al. EUROPEAN RESPIRATORY JOURNAL
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19
- (2020) Christoph D. Spinner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial
- (2020) Anahita Sadeghi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial
- (2020) Remo H M Furtado et al. LANCET
- Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics
- (2020) Magnus Nakrem Lyngbakken et al. Nature Communications
- Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells
- (2020) Lei Shu et al. Stem Cell Research & Therapy
- Clinical trials of disease stages in COVID 19: complicated and often misinterpreted
- (2020) Jay J H Park et al. Lancet Global Health
- Treating Covid-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind, Randomized Controlled Trial in Hospitalized Patients
- (2020) Robert J Ulrich et al. Open Forum Infectious Diseases
- Randomized controlled open label trial on the use of favipiravir combined with inhaled interferon beta-1b in hospitalized patients with moderate to severe COVID-19 pneumonia
- (2020) Faryal Khamis et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19
- (2020) Wesley H. Self et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Systematic examination of preprint platforms for use in the medical and biomedical sciences setting
- (2020) Jamie J Kirkham et al. BMJ Open
- Adaptive platform trials: definition, design, conduct and reporting considerations
- (2019) NATURE REVIEWS DRUG DISCOVERY
- Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols
- (2019) Jay J. H Park et al. Trials
- Global health trials methodological research agenda: results from a priority setting exercise
- (2018) Anna Rosala-Hallas et al. Trials
- WHO R&D Blueprint: a global coordination mechanism for R&D preparedness
- (2017) Marie Paule Kieny et al. LANCET
- Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both
- (2017) Janet Woodcock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Whose Data Are They Anyway? Can a Patient Perspective Advance the Data-Sharing Debate?
- (2017) Charlotte J. Haug NEW ENGLAND JOURNAL OF MEDICINE
- Use of network meta-analysis in clinical guidelines
- (2016) Steve Kanters et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- A Global, Neutral Platform for Sharing Trial Data
- (2016) Barbara E. Bierer et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Platform Trial
- (2015) Scott M. Berry et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Africa Center for Biostatistical Excellence: a proposal for enhancing biostatistics capacity for sub-Saharan Africa
- (2015) Rhoderick Machekano et al. STATISTICS IN MEDICINE
- Capacity building in longitudinal HIV research
- (2015) Skye McGregor et al. Lancet Global Health
- Demystifying trial networks and network meta-analysis
- (2013) E. J. Mills et al. BMJ-British Medical Journal
- Global health funding: how much, where it comes from and where it goes
- (2009) D. McCoy et al. HEALTH POLICY AND PLANNING
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now